FACULTY
![Fatima Al Kaabi Fatima Al Kaabi](https://2023.menactrims.org/wp-content/uploads/2023/11/Fatima-Al-Kaabi.png)
Dr. Fatima Alkaabi
Vice Chair, National MS Society UAE
Executive Director, Abu Dhabi Bone Marrow Transplant Program, Abu Dhabi Stem Cells Center
Abu Dhabi, United Arab Emirates
![Ghalya Alali Photo Ghalya Alali Photo](https://2023.menactrims.org/wp-content/uploads/2023/11/Ghalya-Alali-Photo.png)
Ms. Ghalya Al Ali
Founding Member
National Multiple Sclerosis Society UAE
Abu Dhabi, United Arab Emirates
![Paulina Arce Casillas Paulina Arce Casillas](https://2023.menactrims.org/wp-content/uploads/2023/11/Paulina-Arce-Casillas.png)
Paulina Arce Casillas
Senior Organisational Development and Movement Building Manager
MS International Federation (MSIF)
London, United Kingdom
![Raed-Al-Roughani-Image Raed-Al-Roughani-Image](https://2023.menactrims.org/wp-content/uploads/2023/11/Raed-Al-Roughani-Image.png)
Dr. Raed Alroughani
Consultant Neurologist, Director of MS Clinic
Amiri and Ibn Sina Hospitals
Kuwait City, Kuwait
![NAJOUA ELABKARI Image NAJOUA ELABKARI Image](https://2023.menactrims.org/wp-content/uploads/2023/11/NAJOUA-ELABKARI-Image.png)
Ms. Najoua El Abkari
President, HANASEP
Rabat, Morocco
![Yasmeen-Mitwally-Image Yasmeen-Mitwally-Image](https://2023.menactrims.org/wp-content/uploads/2023/11/Yasmeen-Mitwally-Image.png)
Ms. Yasmin Mitwally
Research and Advocacy Manager
National Multiple Sclerosis Society UAE
Abu Dhabi, United Arab Emirates
![Zoe Burr Zoe Burr](https://2023.menactrims.org/wp-content/uploads/2023/11/Zoe-Burr.png)
Ms. Zoe Burr
Head of Organisational Development and Movement Building
MS International Federation (MSIF)
Liverpool, United Kingdom
![Tim Coeatzee Image Tim Coeatzee Image](https://2023.menactrims.org/wp-content/uploads/2023/11/Tim-Coeatzee-Image.jpg)
Dr. Tim Coetzee
Chief Advocacy, Services & Science Officer
US National MS Society
New York, United States of America
![Joanna Laurson Image Joanna Laurson Image](https://2023.menactrims.org/wp-content/uploads/2023/11/Joanna-Laurson-Image.jpg)
Ms. Joanna Laurson-Doube
International Consultant - Access to Healthcare
Hong Kong, SAR China , Hong Kong
![Douna Haj Ahmed Douna Haj Ahmed](https://2023.menactrims.org/wp-content/uploads/2023/11/Douna-Haj-Ahmed.png)
Ms. Douna Haj Ahmed
Organisational Development and Movement Building Officer
MS International Federation (MSIF)
London, United Kingdom
![](https://2023.menactrims.org/wp-content/plugins/beaver-builder-lite-version/img/pixel.png)
![Ahmed Shatila Image Ahmed Shatila Image](https://2023.menactrims.org/wp-content/uploads/2023/11/Ahmed-Shatila-Image.jpg)
Dr Ahmed Shatila
Consultant Neurologist, Chairman of Medical Advisory Committee
Sheikh Shakhbout Medical City, National Multiple Sclerosis Society UAE
Abu Dhabi, United Arab Emirates
![Bassem Yamout Image Bassem Yamout Image](https://2023.menactrims.org/wp-content/uploads/2023/11/Bassem-Yamout-Image.jpg)
Prof. Bassem I. Yamout
President, Professor of Neurology, Director, Neurology Institute
American University of Beirut, Harley Street Medical Center
Abu Dhabi, United Arab Emirates
![Maya Zeineddine Image Maya Zeineddine Image](https://2023.menactrims.org/wp-content/uploads/2023/01/Maya-Zeineddine-Image-300x300.jpg)
Dr. Maya Zeineddine
Research Manager
Neurology Institute at Harley Street Medical Center
Abu Dhabi, United Arab Emirates
PROGRAM
09:00-10:45 | SESSION 1 | Chair: Joelle Massouh |
---|---|---|
09:00-09:10 | Welcome and Introduction | F. Alkaabi (AE) |
09:10-09:30 | Keynote: Overview of the National MS Society UAE | F. Alkaabi (AE) |
09:30-09:50 | Improving Access to Information in the UAE and the Wider Region | G. Al Ali (AE) |
09:50-10:15 | Q&A with the National MS Society UAE | Moderated by F. Alkaabi (AE) & G. Al Ali (AE) |
10:15-10:45 | Coffee Break | |
10:45-12:15 | Session II: Key Research Updates | Chair: Z. Burr (UK) |
10:45-11:15 | Overview of the Progressive MS Alliance | T. Coetzee (US) |
11:15-12:15 | Key Research Updates from the MENACTRIMS Congress 2023 | R. Alroughani (KW) |
12:15-14:00 | Lunch Break | |
14:00-15:30 | Session III: Access to MS Treatments | Chair: J. Laurson-Doube (UK) |
14:00-14:30 | MENA Access to Treatment Charter | D.H. Ahmed (UK) & P. Arce-Casillas (UK) |
14:30-15:15 | Using MSIF and MENACTRIMS Advocacy Tools | B. Yamout (AE) |
15:15-15:30 | Case Study from Lebanon: How to use the WHO EML to get access to a wider range of DMTs | M. Zeineddine (LB) |
15:30-16:00 | Coffee Break | |
16:00 - 17:00 | Session IV: Access to MS Treatments | Chair: J. Laurson-Doube (UK) |
16:00 -16:15 | Case Study from UAE: Developing National Treatment Guidelines | A. Shatila (AE) & Y. Mitwally (AE) |
16:15-16:30 | Case Study from Morocco: How to use the WHO EML to cover the cost of MS treatment by the health system | N. El Abkari (MA) |
16:30-17:00 | Q&A | Moderated by J. Laurson-Doube (UK) |
TARGET AUDIENCE
MS clinicians interested in learning more about and working with MS organisations, MS organisation representatives.